Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders Publication: Journal Article Shepard, Nate, David Baez-Nieto, Sumaiya Iqbal, Erkin Kurganov, Nikita Budnik, Arthur J. Campbell, Jen Q. Pan, Morgan H Sheng, and Zohreh Farsi. 2024. “Differential Functional Consequences Of GRIN2A mutations Associated With Schizophrenia and Neurodevelopmental Disorders”. Scientific Reports .
Elevated synaptic PKA activity and abnormal striatal dopamine signaling in Akap11 mutant mice, a genetic model of schizophrenia and bipolar disorder Publication: Journal Article Song, Bryan, Yang Ge, Ally Nicolella, Min Jee Kwon, Bart Lodder, Kevin Bonanno, Antia Valle-Tojeiro, et al. 2025. “Elevated Synaptic PKA Activity and Abnormal Striatal Dopamine Signaling In Akap11 mutant Mice, a Genetic Model of Schizophrenia and Bipolar Disorder”. Nature Communications .
Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer’s disease mouse models Publication: Journal Article Dejanovic, Borislav, Tiffany Wu, Ming-Chi Tsai, David Graykowski, Vineela D. Gandham, Christopher M. Rose, Corey E. Bakalarski, et al. 2022. “Complement C1q-Dependent Excitatory and Inhibitory Synapse Elimination by Astrocytes and Microglia in Alzheimer’s Disease Mouse Models”. Nature Aging.
Targeting synapse function and loss for treatment of neurodegenerative diseases Publication: Journal Article Dejanovic, Borislav, Morgan H Sheng, and Jesse E. Hanson. 2024. “Targeting Synapse Function and Loss for Treatment of Neurodegenerative Diseases”. Nature Reviews Drug Discovery.